Herbimycin A in the treatment of experimental proliferative vitreoretinopathy: Toxicity and efficacy study

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 238, Issue 5, 2000, Pages 440-447

  Imai, Kazuyuki ^a   Loewenstein, Anat ^b   Koroma, Barba ^a   Grebe, Rhonda ^a   De Juan Jr , Eugene ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; HERBIMYCIN A; TYROSINE KINASE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; ELECTRORETINOGRAPHY; HISTOLOGY; INFLAMMATION; NONHUMAN; PHOTORECEPTOR; PRIORITY JOURNAL; RABBIT; RECEPTOR BINDING; RETINA DETACHMENT; SKIN FIBROBLAST; VITREORETINOPATHY;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BENZOQUINONES; BIOPSY; CELLS, CULTURED; ELECTRORETINOGRAPHY; ENZYME INHIBITORS; FIBROBLASTS; INJECTIONS; LACTAMS, MACROCYCLIC; PHOTORECEPTORS, VERTEBRATE; PROTEIN-TYROSINE KINASES; QUINONES; RABBITS; RETINAL DETACHMENT; VITREORETINOPATHY, PROLIFERATIVE; VITREOUS BODY;

EID: 0034036278     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004170050376     Document Type: Article

References (38)

1. Aiello LP, Avery RL, Arrigg PG, et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-1487
2. Araiz JJ, Refojo MF, Arroyo MH, et al (1993) Antiproliferative effect of retinoic acid in intravitreous silicone oil in an animal model of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 34:522-530
3. Barrada A, Peyman GA, Case J, et al (1984) Evaluation of intravitreal 5-fluorouracil, vincristine, VP 16, doxorubicin, and thiotepa in primate eyes. Ophthalmic Surg 15:767-769
4. Baudouin C, Fredj RD, Ettaiche M, et al (1992) Induction of experimental proliferative vitreoretinopathy in the rabbit eye by intravitreal injections of fibroblast growth factor. Lens Eye Toxic Res 9:505-511
5. Blumenkranz MS, Ophir A, Claflin AJ, et al (1982) Fluorouracil for the treatment of massive periretinal proliferation. Am J Ophthalmol 94:458-467
6. Campochiaro PA, Jerdan JA, Glaser BM, et al (1985) Vitreous aspirates from patients with proliferative vitreoretinopathy stimulate retinal pigment epithelial cell migration. Arch Ophthalmol 193:1403-1405
7. Campochiaro PA, Kaden IH, Vidaurri LJ, et al (1985) Cryotherapy enhances intravitreal dispersion of viable retinal pigment epithelial cells. Arch Ophthalmol 103:434-436
8. Campochiaro PA, Bryan JA 3d, Conway BP, et al (1986) Intravitreal chemotactic and mitogenic activity. Implication of blood-retinal barrier breakdown. Arch Ophthalmol 104:1685-1687
9. Chandler DB, Quansah FA, Hida T, Machemer R (1986) A refined experimental model for proliferative vitreoretinopathy. Graefe's Arch Clin Exp Ophthalmol 224:86-91
10. Connor TB, Roberts AB, Sporn MB, et al (1989) Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J Clin Invest 83:1661-1666
11. Fredj RD, Baudouin C, Negre F, et al (1991) Acidic FGF and other growth factors in preretinal membranes from patients with diabetic retinopathy and proliferative vitreoretinopathy. Ophthalmic Res 23:154-161
12. Fukazawa H, Uehara Y, Murakami Y, et al (1994) Labeling of v-Src and BCR-ABL tyrosine kinases with [14C] herbimycin A and its use in the elucidation of the kinase inactivation mechanism. FEBS Lett 340:155-158
13. Gaudric A, Glacet BA, Clement G, et al (1990) Transforming growth factor beta in the vitreous of patients with epiretinal proliferation. Ophthalmologie 4:51-52
14. Hida T, Chandler DB, Sheta SM (1987) Classification of the stages of proliferative vitreoretinopathy in refined experimental model in the rabbit eye. Graefe's Arch Clin Exp Ophthalmol 225:303-307
15. Hiscott PS, Grierson I, Trombetta CJ, et al (1984) Retinal and epiretinal glia - an immunohistochemical study. Br J Ophthalmol 68:698-707
16. Kirmani M, Santana M, Sorgente N, et al (1983) Antiproliferative drugs in the treatment of experimental proliferative vitreoretinopathy. Retina 3:269-272
17. Laqua H, Machemer R (1975) Glial cell proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol 80:602-618
18. Li PM, Fukazawa H, Yamamoto C, et al (1993) Method of identifying inhibitors of oncogenic transformation: selective inhibition of cell growth in serum-free medium. Oncogene 8:1731-1735
19. Machemer R, Laqua H (1975) Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol 80:1-23
20. Machemer R, van Horn HD, Aaberg TM (1978) Pigment epithelial proliferation in human retinal detachment with massive periretinal proliferation. Am J Ophthalmol 85:181-191
21. Machemer R, Sugita G, Tano Y (1979) Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc 77:171-180
22. Muroya K, Hashimoto Y, Hattori S, et al (1992) Specific inhibition of NGF receptor tyrosine kinase activity by K-252a. Biochim Biophys Acta 1135:353-356
23. Newsome DA, Rodrigues MM, Machemer R (1981) Human massive periretinal proliferation. In vitro characteristics of cellular components. Arch Ophthalmol 99:873-880
24. Omura S, Iwai Y, Takahashi Y, et al (1979) Herbimycin, a new antibiotic produced by a strain of Streptomyces. J Antibiot (Tokyo) 32:255-261
25. Peyman GA, Greenberg D, Fishman GA, et al (1984) Evaluation of toxicity of intravitreal antineoplastic drugs. Ophthalmic Surg 15:411-413
26. Rebut BC, Boutemy RS, Evain BD (1993) Modulation of pp60c-srs activity and cellular localization during differentiation of human trophoblast cells in culture. J Cell Sci 105:629-636
27. Robbins SG, Mixon RN, Wilson DJ, et al (1994) Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest Ophthalmol Vis Sci 35:3649-3663
28. Santana M, Wiedemann P, Kirmani M, et al (1984) Daunomycin in the treatment of experimental proliferative vitreoretinopathy: retinal toxicity of intravitreal daunomycin in the rabbit. Graefe's Arch Clin Exp Ophthalmol 221:210-213
29. Steinhorst UH, Chen EP, Hatchell DL, et al (1993) Aclacinomycin A in the treatment of experimental proliferative vitreoretinopathy. Efficacy and toxicity in the rabbit eye. Invest Ophthalmol Vis Sci 34:1753-1760
30. Steinhorst UH, Chen EP, Machemer R, et al (1993) N,N-Dimethyladriamycin for treatment of experimental proliferative vitreoretinopathy: efficacy and toxicity on the rabbit retina. Exp Eye Res 56:489-495
31. Steinhorst UH, Hatchell DL, Chen EP, et al (1993) Ocular toxicity of daunomycin: effects of subdivided doses on the rabbit retina after vitreous gas compression. Graefe's Arch Clin Exp Ophthalmol 231:591-594
32. Sunalp MA, Wiedemann P, Sorgente N, et al (1985) Effect of adriamycin on experimental proliferative vitreoretinopathy in rabbit. Exp Eye Res 41:105-115
33. Uehara Y, Fukazawa H, Murakami Y, Mizuno S (1989) Irreversible inhibition of v-src tyrosine kinase activity by herbimycin A and its abrogation by sulfhydryl compounds. Biochem Biophys Res Commun 163:803-809
34. van Bockxmeer F, Martin CE, Thompson DE, et al (1985) Taxol for the treatment of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 26:1140-1147
35. Vinores SA, Campochiaro PA, Lee A (1990) Localization of blood-retinal barrier breakdown in human pathologic specimens by immunohistochemical staining for albumin. Lab Invest 62:742-750
36. Weller M, Esser P, Heimann K, et al (1991) Retinal microglia: a new cell in idiopathic proliferative vitreoretinopathy? Exp Eye Res 53:275-281
37. Yamashita H, Hori S, Mascuda K (1989) Population and proportion of component cells in preretinal membranes. Jpn J Ophthalmol 30:269-281
38. Yeo JH, Sadeghi J, Campochiaro PA, et al (1986) Intravitreous fibronectin and platelet-derived growth factor. New model for traction retinal detachment. Arch Ophthalmol 104:417-421